From left to right: Bernard Majoie of la Fondation Fournier Majoie, Jonathan Yeh, Senior Advisor at IRICoR, Anne Marinier, Principal Investigator and director of medicinal chemistry at IRIC, Laurent Meijer of Manros Therapeutics, Véronique Messier of the Law Firm Messier Udashkin CPA, Jacques Bernard Taste of Biotech Finances, Anissa Mansour of Crescentia Consulting, Didier Bœuf, Nadine Beauger, General Director at IRICoR, Stéphane Silvente of Affichem, Manon Valiquette, Manager, Scientifics Core Facility at IRIC and Pierre-Emanuel Gérard of Biomunex
On October 12th, 2016, as part of the “Opération Connexions-Pros Québec” organized by Biotech Finances, The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal and its not-for-profit drug discovery and commercialization centre, IRICoR, welcomed French and Belgian bio entrepreneurs to discuss about good practices in Innovation and Research Valuation.